Version 5.4
Interaction: Rara :: Pabpc1 XML
Summary
InnateDB Group ID 313960
Short name Rara :: Pabpc1
Full name Rara interacts with Pabpc1
Interaction type physical association
Participants
Participant 1
Molecule: IDBG-210842
Molecule type: protein
Species: Mus musculus
MGI: Rara
Full name: retinoic acid receptor, alpha
Direction: input
Biological role: unspecified role
Participant 2
Molecule: IDBG-135334
Molecule type: protein
Species: Mus musculus
MGI: Pabpc1
Full name: poly(A) binding protein, cytoplasmic 1
Direction: input
Biological role: unspecified role
Evidence Reference 1
InnateDB ID IDB-989947.1
Last Modified 2013-07-09
Review status Unreviewed by InnateDB [Report errors or provide feedback]
Source database BIOGRID
Source database ID BIOGRID-854046
PMID 18495661
Interaction detection method affinity chromatography technology
Host system invitro
Host organism
Cell status
Cell line
Cell type
Tissue type
Comment
Participants
Participant Identification Method Experimental Role Participant Accession
1) Rara predetermined participant bait 19401
2) Pabpc1 predetermined participant prey NP_032800
Evidence Reference 2
InnateDB ID IDB-991134.1
Last Modified 2013-07-09
Review status Unreviewed by InnateDB [Report errors or provide feedback]
Source database BIOGRID
Source database ID BIOGRID-854031
PMID 18495661
Interaction detection method affinity chromatography technology
Host system invitro
Host organism
Cell status
Cell line
Cell type
Tissue type
Comment
Participants
Participant Identification Method Experimental Role Participant Accession
1) Rara predetermined participant bait 19401
2) Pabpc1 predetermined participant prey NP_032800

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca